109 related articles for article (PubMed ID: 26405677)
21. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.
Erb P; Battegay M; Zimmerli W; Rickenbach M; Egger M
Arch Intern Med; 2000 Apr; 160(8):1134-40. PubMed ID: 10789606
[TBL] [Abstract][Full Text] [Related]
22. Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012.
Cohen S; Smit C; van Rossum AM; Fraaij PL; Wolfs TF; Geelen SP; Schölvinck EH; Warris A; Scherpbier HJ; Pajkrt D;
AIDS; 2013 Oct; 27(16):2567-75. PubMed ID: 23842124
[TBL] [Abstract][Full Text] [Related]
23. Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria--Implications for Care.
Kuti MA; Adesina OA; Awolude OA; Ogunbosi BO; Fayemiwo SA; Akinyemi JO; Adetunji AA; Irabor AE; Odaibo GN; Prosper O; Taiwo BO; Olaleye D; Murphy RL; Kanki P; Adewole IF
J Int Assoc Provid AIDS Care; 2015; 14(4):355-9. PubMed ID: 25331224
[TBL] [Abstract][Full Text] [Related]
24. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
25. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
[TBL] [Abstract][Full Text] [Related]
26. Short Intracellular HIV-1 Transcripts as Biomarkers of Residual Immune Activation in Patients on Antiretroviral Therapy.
Ishizaka A; Sato H; Nakamura H; Koga M; Kikuchi T; Hosoya N; Koibuchi T; Nomoto A; Kawana-Tachikawa A; Mizutani T
J Virol; 2016 Jun; 90(12):5665-5676. PubMed ID: 27030274
[TBL] [Abstract][Full Text] [Related]
27. Association of Multiple Primary Skin Cancers With Human Immunodeficiency Virus Infection, CD4 Count, and Viral Load.
Asgari MM; Ray GT; Quesenberry CP; Katz KA; Silverberg MJ
JAMA Dermatol; 2017 Sep; 153(9):892-896. PubMed ID: 28700773
[TBL] [Abstract][Full Text] [Related]
28. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial haplogroup H is related to CD4+ T cell recovery in HIV infected patients starting combination antiretroviral therapy.
Medrano LM; Gutiérrez-Rivas M; Blanco J; García M; Jiménez-Sousa MA; Pacheco YM; Montero M; Iribarren JA; Bernal E; Martínez OJ; Benito JM; Rallón N; Resino S;
J Transl Med; 2018 Dec; 16(1):343. PubMed ID: 30522500
[TBL] [Abstract][Full Text] [Related]
30. HIV treatment outcomes following antiretroviral therapy initiation and monitoring: A workplace program in Papua, Indonesia.
Limmade Y; Fransisca L; Rodriguez-Fernandez R; Bangs MJ; Rothe C
PLoS One; 2019; 14(2):e0212432. PubMed ID: 30802257
[TBL] [Abstract][Full Text] [Related]
31. Improvement in insulin sensitivity and serum leptin concentration after the switch from a ritonavir-boosted PI to raltegravir or dolutegravir in non-diabetic HIV-infected patients.
Calza L; Colangeli V; Borderi M; Coladonato S; Tazza B; Bon I; Re MC; Viale P
J Antimicrob Chemother; 2019 Mar; 74(3):731-738. PubMed ID: 30541118
[TBL] [Abstract][Full Text] [Related]
32. Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients.
Bastard JP; Soulié C; Fellahi S; Haïm-Boukobza S; Simon A; Katlama C; Calvez V; Marcelin AG; Capeau J
Antivir Ther; 2012; 17(5):915-9. PubMed ID: 22436412
[TBL] [Abstract][Full Text] [Related]
33. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
[TBL] [Abstract][Full Text] [Related]
34. Factors associated with therapeutic success in HIV-positive individuals in southern Brazil.
Silveira MP; Maurer P; Guttier MC; Moreira LB
J Clin Pharm Ther; 2015 Apr; 40(2):192-5. PubMed ID: 25422132
[TBL] [Abstract][Full Text] [Related]
35. Low HDL-cholesterol among HIV-1 infected and HIV-1 uninfected individuals in Nairobi, Kenya.
Njoroge A; Guthrie BL; Bosire R; Wener M; Kiarie J; Farquhar C
Lipids Health Dis; 2017 Jun; 16(1):110. PubMed ID: 28599673
[TBL] [Abstract][Full Text] [Related]
36. [GESIDA/National AIDS Plan: Consensus document on antiretroviral therapy in adults infected by the human immunodeficiency virus (Updated January 2015)].
Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):543.e1-43. PubMed ID: 25959461
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
38. High-density lipoprotein cholesterol in HIV-infected patients: evidence for an association with HIV-1 viral load, antiretroviral therapy status, and regimen composition.
Bernal E; Masiá M; Padilla S; Gutiérrez F
AIDS Patient Care STDS; 2008 Jul; 22(7):569-75. PubMed ID: 18479224
[TBL] [Abstract][Full Text] [Related]
39. Low blood CD8+ T-lymphocytes and high circulating monocytes are predictors of HIV-1-associated progressive encephalopathy in children.
Sánchez-Ramón S; Bellón JM; Resino S; Cantó-Nogués C; Gurbindo D; Ramos JT; Muñoz-Fernández MA
Pediatrics; 2003 Feb; 111(2):E168-75. PubMed ID: 12563091
[TBL] [Abstract][Full Text] [Related]
40. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
